The stock of her biopharmaceutical firm Biocon dropped 26% in the past 12 months.

FORBES: India's 40 Richest

Since 2005 Shaw has turned over at least half of her annual Biocon dividends to these programs.

FORBES: By Anuradha Raghunathan

The deal will bolster revenue as Kiran Mazumdar-Shaw, Biocon's ambitious boss, continues to invest in new biotech drugs.

ECONOMIST: The drugs industry

Kiran Mazumdar-Shaw started one of India's first biotech companies, Biocon (otcbb: BCLTF - news - people ).

FORBES: India's Most Powerful Businesswomen

Biocon cut its dividend in 2009 and 2010 during the global financial crisis, but Shaw says she maintained her same level of donations.

FORBES: By Anuradha Raghunathan

Kiran Mazumdar-Shaw started one of India's first biotech companies, Biocon.

FORBES: Magazine Article

Lastly, the leaders of three generic companies, Actavis, Biocon, and Cipla were rewarded for doing what was long dismissed as impossible: building profitable companies by selling medicines at cut-rate prices.

FORBES: Connect

Pfizer will license insulin products from India's Biocon.

ECONOMIST: The drugs industry